Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co Says FY Revenue RMB645.3 Mln
March 29 (Reuters) - Jilin Province Huinan Changlong
Bio-Pharmacy Co Ltd 8049.HK :
* FY REVENUE RMB645.3 MILLION VERSUS RMB654.1 MILLION
* FY PROFIT ATTRIBUTABLE RMB144.4 MILLION VERSUS RMB142.7
MILLION
Source text for Eikon: ID:nHKS8fVS4M
Further company coverage: 8049.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jilin Province Huinan Changlong Bio-pharmacy
See all newsJilin Changlong Bio-pharmacy interim profit rises on lower costs
Brief: Jilin Province Huinan Changlong Bio-pharmacy Posts H1 Revenue Of RMB 435 million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Profit For Year Attributable Rmb198.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Structured Deposit Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product For RMB50 MLN